Presentation TVT 2013 Pharmacotherapy Alternatives During and After TAVR: Is There an Optimal Regimen? Presenter: Corrado Tamburino June 12, 2013
Presentation TVT 2013 An Anticoagulated Patient with Severe Paravalvular Regurgitation and Ostial Left Main Disease Presenter: Peter Pollak June 12, 2013
Presentation TVT 2013 The Landscape of Dedicated Transfemoral Closure Devices for TAVR Presenter: Eberhard Grube June 12, 2013
Presentation TVT 2013 Baseline Frailty Status of the "Extreme Risk" Patients in the US CoreValve Trial Presenter: Jeffrey Popma June 12, 2013
Presentation TVT 2013 The "Essential Primer" on Surgical Risk Scores: Key Take-home Messages Presenter: Todd Dewey June 12, 2013
Presentation TVT 2013 Defining and Measuring Frailty in Aortic Stenosis Patients: From the Eyeball Test to Objective Tools Presenter: Philip Green June 12, 2013
Presentation TVT 2013 Early Clinical Experiences with the Entourage TA-TAVR System Presenter: Raj Makkar June 12, 2013
Presentation TVT 2013 Transseptal Strategies in Challenging Transcatheter Aortic Valve-in-Valve Implantation Presenter: Simon Cheung Chi Lam June 12, 2013
Presentation TVT 2013 First-in-human case with a dedicated fully percutaneous TAVR system for pure aortic insufficiency Presenter: Marco Barbanti June 12, 2013